Navigation Links
Neuralstem Updates ALS Stem Cell Trial Progress
Date:5/8/2012

ed an IND (Investigational New Drug) application to the FDA for a Phase I safety trial in chronic spinal cord injury.

Neuralstem also has the ability to generate stable human neural stem cell lines suitable for the systematic screening of large chemical libraries. Through this proprietary screening technology, Neuralstem has discovered and patented compounds that may stimulate the brain's capacity to generate new neurons, possibly reversing the pathologies of some central nervous system conditions.  The company has received approval from the FDA to conduct a Phase Ib safety trial evaluating NSI-189, its first small molecule compound, for the treatment of major depressive disorder (MDD).  Additional indications could include schizophrenia, Alzheimer's disease and bipolar disorder.

For more information, please visit www.neuralstem.com or connect with us on Twitter and Facebook.

Cautionary Statement Regarding Forward Looking Information

This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding potential applications of Neuralstem's technologies constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Neuralstem's periodic reports, including the annu
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Neuralstem Announces Issuance of Core Technology Patent in Europe
2. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
3. Neuralstems ALS Trial on Clinical Hold
4. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
5. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
6. Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
7. Neuralstem Updates ALS Clinical Trial Progress
8. Dr. Eva Feldman, Principal Investigator, Presents Interim Safety Results for Neuralstem ALS Trial
9. Neuralstem Updates NSI-189 Major Depression Trial
10. Neuralstem Announces Notice of Allowance for Two Additional Neurogenic Compound Patents
11. Dr. Eva Feldman, Principal Investigator, Presents Interim Data on Neuralstem ALS Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- TWi Pharmaceuticals, Inc. (4180.TT) today announced that it ... Food and Drug Administration (FDA) on its Abbreviated ... oral suspension, the generic equivalent to Par Pharmaceutical,s ... Hatch Waxman rules, it will be entitled to ... the pre-launch preparation of the generic drug.  However, ...
(Date:8/27/2014)... About 8 million Americans have peripheral arterial ... fatty plaque in the arteries, according to recent statistics. ... in incidences of diabetes and obesity, the Society ... Arterial RevascularizatioN (LEARN) meeting, Oct. 9–11 in ... residents and fellows will be able to gain state-of-the-art ...
(Date:8/27/2014)... --  Los Angeles orthodontics expert, Dr. Isaac ... want to make their treatment even faster. With this ... patients have a powerful tool to use as they ... by most patients with all types of braces, letting ... AcceleDent® Aura system for a few minutes each day. ...
Breaking Medicine Technology:TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Los Angeles Orthodontist, Dr. Isaac Hakim, is Now Offering AcceleDent Aura 2
... 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") ... in-vitro diagnostic ("IVD") company, today announced that Chengxuan, a ... Chairman and Chief Executive Officer of the Company, informed ... American Depositary Shares ("ADSs") in the open market on ...
... of Disabled Adults and Children (FODAC) has partnered with Invacare ... of equipment and supplies to Joplin, Missouri. A massive F5 ... 2011, leaving much of the city in ruins. FODAC, with ... supply shipment to Joplin within 24 hours of the disaster. ...
Cached Medicine Technology:China Medical Technologies Announces the Purchase of its ADSs by Chengxuan in the Open Market 2Friends of Disabled Adults and Children Partners With Invacare to Provide Aid in Wake of Joplin Tornado 2Friends of Disabled Adults and Children Partners With Invacare to Provide Aid in Wake of Joplin Tornado 3
(Date:8/27/2014)... 2014 DiaSorin has announced that their ... Dihydroxyvitamin D,” will feature guest speaker Dr. Gregory A. ... for Health and Healing Integrative Medicine. Dr. Plotnikoff serves ... Institute for Health and Healing and as Senior Consultant, ... Minnesota. He also serves as a co-editor of the ...
(Date:8/27/2014)... Recently, Skmen.com, a renowned garment manufacturer and ... bodycon dresses . The company has rich experience in ... items in stock and ready to ship: celebrity bodycon ... sweater dresses and so forth. All of them are ... “We are proud to announce the new collection of ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Taking its popular ... Steele Creek YMCA will host its largest crowd ... on Saturday, September 13 at YMCA Camp Thunderbird . ... race divisions: adult, youth and teams. Within each division, ... to their physical limit - for a worthy cause. ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Today, Zane ... webinar on compliance tips for administering a premium reimbursement ... reform in full effect, compliance is top of mind ... transition to individual health insurance and premium reimbursement, there ... , In the 35 minute webinar, Zane Benefits President, ...
(Date:8/27/2014)... Skirt Sports , the innovative women’s ... pioneer runner, Kathrine Switzer, most noted for her brave running ... a line of women’s running clothes that unites the history ... 261 Fearless Movement. , “It is such an ... DeBoom. “Kathrine is the original Skirt – she stood ...
Breaking Medicine News(10 mins):Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 2Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 3Health News:Skmen.com Unveils Its New Celebrity Bodycon Dresses for Its Loyal Customers 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:Zane Benefits Announces Upcoming Webinar on Compliance 2Health News:Skirt Sports Launches Clothing Line with Legendary Runner Kathrine Switzer 2
... ... through its ActiveBase Security™ solution, today announced it has been included in the list of ... Joseph Feiman, Neil MacDonald, John Pescatore, Earl Perkins April 14, 2010, by Gartner Inc. ... Tel Aviv, Israel (PRWEB) April ...
... cases stem from established risk factors, study finds, , ... to increase the odds of breast cancer in white women ... , For instance, for postmenopausal women in the study, "recent ... to play as big a role in Hispanics," said Dr. ...
... ... Spearhead Company,s Quality, Regulatory and Compliance Matters , ... Panama City, Fla. (PRWEB) April 26, 2010 -- ... appointment of Samuel Patton as the company’s chief quality and regulatory officer. He will ...
... ... publishes new e-book that helps people choose the right dentist to perform dental implant surgery. ... (PRWEB) April 26, ... launched her newest e-book, Dental Implants: The Five Questions You Must Ask Your ...
... ... announced a small business Internet video advertising program that can deliver first ... required for traditional web page search engine optimization. The Site Steering small ... promotional video, and using a proprietary method to distribute the video to ...
... BMJ , Nigel Hawkes, freelance journalist and Director of Straight ... investigates how the way that patients are allocated diagnostic codes ... hospital,s performance. It follows two articles published by ... rates to judge hospital performance is a bad idea. ...
Cached Medicine News:Health News:Leading Industry Analyst Firm Names ActiveBase "Cool Vendor" 2Health News:Leading Industry Analyst Firm Names ActiveBase "Cool Vendor" 3Health News:Leading Industry Analyst Firm Names ActiveBase "Cool Vendor" 4Health News:Breast Cancer Risks Not Same for Hispanic Women 2Health News:Breast Cancer Risks Not Same for Hispanic Women 3Health News:iSirona Appoints Chief Quality and Regulatory Officer to Oversee Quality Initiatives 2Health News:New E-Book Explains the Facts About Dental Implants 2Health News:Site Steering Launches Keyword Targeted Small Business Internet Video Advertising Program That Achieves First Page Search Results Within Days 2Health News:Site Steering Launches Keyword Targeted Small Business Internet Video Advertising Program That Achieves First Page Search Results Within Days 3Health News:Is patient coding making hospitals appear better than they are? 2
... Captia Borrelia burgdorferi (B. burgdorferi) IgG/IgM Enzyme ... the qualitative presumptive (firststep) detection of total ... serum. This ELISA should only be used ... are consistent with Lyme disease. Equivocal or ...
POLYSORB™ sutures are composed of LACTOMER™ glycolide/lactide copolymer which is a synthetic polyester composed of glycolide and lactide (derived from glycolic and lactic acids)....
SURGIPRO™ BLUE Monofilament Suture in two sizes....
Surgitie&trade Single Use Ligating Loops with Delivery System...
Medicine Products: